ORIGINAL RESEARCH
Accepted on 05 Jan 2026
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Novel Immune Markers and Predictive Models for Diagnosis, Immunotherapy and Prognosis in Lung Cancer
Novel Immune Markers and Predictive Models for Diagnosis, Immunotherapy and Prognosis in Lung Cancer
58
Total downloads
5,857
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 25 Dec 2025
Multi-omics Integration and Machine Learning Identify NPC2 as a Prognostic and Treatment-Responsive Regulator in Lung Adenocarcinoma
ORIGINAL RESEARCH
Published on 12 Dec 2025
Prediction of first-line immunotherapy response in patients with extensive-stage small cell lung cancer using a clinical-radiomics combined model
doi 10.3389/fimmu.2025.1688012
- 1,070 views
ORIGINAL RESEARCH
Published on 09 Dec 2025
Multiomics analysis demonstrated that TOPBP1 interacting checkpoint and Replication Regulator may serve as an immune-related biomarker indicative of poor prognosis in lung adenocarcinoma
doi 10.3389/fimmu.2025.1740279
- 1,223 views
ORIGINAL RESEARCH
Published on 28 Nov 2025
DDR1 as a key prognostic biomarker in non-small cell lung cancer: identification, validation, and potential therapeutic implications
doi 10.3389/fimmu.2025.1690829
- 1,266 views
ORIGINAL RESEARCH
Published on 31 Oct 2025
To predict the spread through air spaces in lung adenocarcinoma using radiomic features from different regions of part-solid nodules: a multicenter study
doi 10.3389/fonc.2025.1700843
- 897 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: